|
0
|
|
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers.
(journals.asm.org)
|
Jongo S
…
Specht S
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#infection
#clinical trial
#bioavailability
#helminth
|
|
0
|
|
Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine.
(nature.com)
|
Kallas EG
…
Lacerda MVG
Nature Medicine
2026-04-01
|
#vaccination
#clinical trial
#immunogenicity
#dengue
|
|
0
|
|
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial.
(nature.com)
|
Mellema JJ
…
van der Heijden MS
Nature Medicine
2026-04-01
|
#clinical trial
#immunotherapy
#bladder cancer
#chemoradiotherapy
|
|
0
|
|
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial.
(nature.com)
|
Ploquin A
…
Dropulic LK
Nature Medicine
2026-04-01
|
#vaccination
#clinical trial
#rna
#immunogenicity
#zoonosis
|
|
0
|
|
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.
(nature.com)
|
Wainberg ZA
…
O'Reilly EM
Nature Medicine
2026-04-01
|
#cancer
#clinical trial
#immunotherapy
#biomarker
#chemotherapy
|
|
0
|
|
Mazdutide versus placebo in Chinese adults with type 2 diabetes.
(nature.com)
|
Zhu D
…
Qian L
Nature
2026-04-01
|
#metabolism
#clinical trial
#diabetes
#pharmacology
|
|
0
|
|
Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE).
(linkinghub.elsevier.com)
|
Yacoub S
…
Munblit D
Lancet Infectious Diseases
2026-04-01
|
#clinical trial
#outcomes
#dengue
#consensus
|
|
0
|
|
Pharmacokinetics, safety, and tolerability of HRS-8427, a novel anti-carbapenem-resistant cephalosporin, in healthy subjects.
(journals.asm.org)
|
Yin T
…
Hu W
Antimicrobial Agents and Chemotherapy
2026-04-01
|
#pharmacokinetics
#amr
#clinical trial
#antibiotic
|
|
0
|
|
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil.
(linkinghub.elsevier.com)
|
Buerger V
…
Jaramillo JC
Lancet Infectious Diseases
2026-04-01
|
#vaccination
#clinical trial
#immunogenicity
#live-attenuated
#chikungunya
|
|
0
|
|
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.
(nature.com)
|
Huang Z
…
Zhang Y
Nature Medicine
2026-04-01
|
#cancer
#clinical trial
#immunotherapy
#chemotherapy
#chronotherapy
|
|
0
|
|
LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial.
(nature.com)
|
Mabrouk OS
…
Graham DL
Nature Medicine
2026-04-01
|
#clinical trial
#pharmacodynamics
#neurodegeneration
#antisense
#neuropathology
|
|
0
|
|
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes.
(nature.com)
|
Guo L
…
Yang W
Nature
2026-04-01
|
#metabolism
#clinical trial
#diabetes
#pharmacotherapy
|
|
0
|
|
A small-molecule inverse agonist of PPARgamma for advanced solid tumors: a phase 1 trial.
(nature.com)
|
Galsky MD
…
Gao X
Nature Medicine
2026-04-01
|
#cancer
#clinical trial
#toxicity
#drug
|